Morphine and alternative opioids in cancer pain: the EAPC recommendations
By G. Hanks, F. Conno, N. Cherny, M. Hanna, E. Kalso, Henry McQuay, S. Mercadante, J. Meynadier, P. Poulain, C. Ripamonti and 5 more. British Journal of Cancer, 2001
848 citations recorded by the source corpus.
An expert working group of the European Association for Palliative Care has revised and updated its guidelines on the use of morphine in the management of cancer pain. The revised recommendations presented here give guidance on the use of morphine and the alternative strong opioid analgesics which have been introduced in many parts of the world in recent years. Practical strategies for dealing with difficult situations are described presenting a consensus view where supporting evidence is lacking. The strength of the evidence on which each recommendation is based is indicated. © 2001 Cancer Research Campaign
Subfields: Anesthesiology and Pain Medicine, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/5b2306ad3daebc70c881a3983728fb0c1ca59bfb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Montanari
- L. Moja
- Giovanni Apolone
- S. Deandrea
Citations in the corpus
- Prevalence of undertreatment in cancer pain. A review of published literature. (2008, background): “Despite the diffusion of several guidelines for cancer pain management, including well-known recommendations of the World Health Organization (WHO) [3], the Agency for Health Care Policy and Research (AHCPR) [4] and the Expert Working Group of the European Association for the Palliative Care [5] and”